Effects of blood pressure lowering in patients with acute ischemic stroke and carotid artery stenosis

International Journal of Stroke

Volumn 10, Issue 3, 2015, Pages 354-359

  Jusufovic, Mirza ^a   Sandset, Else Charlotte ^a   Bath, Philip M W ^b   Karlson, Björn W ^c,d   Berge, Eivind ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c ASTRAZENECA R AND D   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Acute stroke; Blood pressure; Candesartan; Carotid stenosis; Cerebral autoregulation

Indexed keywords

CANDESARTAN; PLACEBO; ANTIHYPERTENSIVE AGENT; BENZIMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CARDIAC IMAGING; CAROTID ARTERY OBSTRUCTION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; VERY ELDERLY; ANALYSIS OF VARIANCE; BLOOD PRESSURE; COMPLICATION; DRUG EFFECTS; MIDDLE AGED; SCANDINAVIA; STROKE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BLOOD PRESSURE; BRAIN ISCHEMIA; CAROTID STENOSIS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; SCANDINAVIAN AND NORDIC COUNTRIES; STROKE; TETRAZOLES; TREATMENT OUTCOME;

EID: 84924916455     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12418     Document Type: Article

References (32)

1. Wolff T, Guirguis-Blake J, Miller T, Gillespie M, Harris R. Screening for carotid artery stenosis: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2007; 147:860-870.
2. Spence JD. Management of resistant hypertension in patients with carotid stenosis: high prevalence of renovascular hypertension. Cerebrovasc Dis 2000; 10:249-254.
3. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA, IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002; 33:1315-1320.
4. Sprigg N, Gray LJ, Bath PM etal. Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial. J Hypertens 2006; 24:1413-1417.
5. Qureshi AI, Ezzeddine MA, Nasar A etal. Prevalence of elevated blood pressure in 563, 704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med 2007; 25:32-38.
6. van der Grond J, Balm R, Kappelle LJ etal. Cerebral metabolism of patients with stenosis or occlusion of the internal carotid artery. A 1H-MR spectroscopic imaging study. Stroke 1995; 26:822-828.
7. Vernieri F, Pasqualetti P, Passarelli F, Rossini PM, Silvestrini M. Outcome of carotid artery occlusion is predicted by cerebrovascular reactivity. Stroke 1999; 30:593-598.
8. Powers WJ. Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol 1991; 29:231-240.
9. Grubb RL Jr, Derdeyn CP, Fritsch SM etal. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 1998; 280:1055-1060.
10. Rothwell PM, Howard SC, Spence JD. Carotid Endarterectomy Trialists' Collaboration. Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke 2003; 34:2583-2590.
11. Sandset EC, Bath PM, Boysen G etal. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 2011; 377:741-750.
12. Sandset EC, Murray G, Boysen G etal. Angiotensin receptor blockade in acute stroke. The Scandinavian Candesartan Acute Stroke Trial: rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003). Int J Stroke 2010; 5:423-427.
13. European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991; 337:1235-1243.
14. North American Symptomatic Carotid Endarterectomy Trial Steering Committee. North American symptomatic carotid endarterectomy trial. Methods, patient characteristics, and progress. Stroke 1991; 22:711-720.
15. Jauch EC, Saver JL, Adams HP etal. American heart association stroke council; council on cardiovascular nursing; council on peripheral vascular disease; council on clinical cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44:870-947.
16. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25:457-507.
17. Sare GM, Gray LJ, Wardlaw J, Chen C, Bath PM. Is lowering blood pressure hazardous in patients with significant ipsilateral carotid stenosis and acute ischaemic stroke? Interim assessment in the 'Efficacy of Nitric Oxide in Stroke' trial. Blood Press Monit 2009; 14:20-25.
18. Paciaroni M, Agnelli G, Caso V etal. Effect of carotid stenosis on the prognostic value of admission blood pressure in patients with acute ischemic stroke. Atherosclerosis 2009; 206:469-473.
19. Stead LG, Gilmore RM, Decker WW, Weaver AL, Brown RD Jr. Initial emergency department blood pressure as predictor of survival after acute ischemic stroke. Neurology 2005; 65:1179-1183.
20. Vemmos KN, Tsivgoulis G, Spengos K etal. U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J Intern Med 2004; 255:257-265.
21. Britton M, de Faire U, Helmers C. Hazards of therapy for excessive hypertension in acute stroke. Acta Med Scand 1980; 207:253-257.
22. Ruff RL, Talman WT, Petito F. Transient ischemic attacks associated with hypotension in hypertensive patients with carotid artery stenosis. Stroke 1981; 12:353-355.
23. Nishimura Y, Ito T, Saavedra JM. Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 2000; 31:2478-2486.
24. Fornes P, Richer C, Vacher E, Bruneval P, Giudicelli JF. Losartan's protective effects in stroke-prone spontaneously hypertensive rats persist durably after treatment withdrawal. J Cardiovasc Pharmacol 1993; 22:305-313.
25. Inada Y, Wada T, Ojima M etal. Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens 1997; 19:1079-1099.
26. Wada T, Kanagawa R, Ishimura Y, Inada Y, Nishikawa K. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats. J Hypertens 1995; 13:113-122.
27. Walters MR, Bolster A, Dyker AG, Lees KR. Effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease. Stroke 2001; 32:473-478.
28. Schrader J, Luders S, Kulschewski A etal. The ACCESS Study: evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke 2003; 34:1699-1703.
29. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358:1033-1041.
30. Schrader J, Luders S, Kulschewski A etal. Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES). Stroke 2005; 36:1218-1226.
31. Yusuf S, Diener HC, Sacco RL etal. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 2008; 359:1225-1237.
32. The ENOS Trial Investigators. Glyceryl trinitrate vs. control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122). Int J Stroke 2006; 1:245-249.